Efforts to repeat the success of first-in-class drugs targeting the DNA damage response (DDR) have so far failed to deliver. Poly(ADP)ribose polymerase (PARP) inhibitors, which are drugs that exploit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results